Compounds > sch 42495
Page last updated: 2024-09-03

sch 42495 and sch 34826

sch 42495 has been researched along with sch 34826 in 2 studies

Compound Research Comparison

Studies
(sch 42495)		Trials
(sch 42495)		Recent Studies (post-2010)
(sch 42495)		Studies
(sch 34826)		Trials
(sch 34826)		Recent Studies (post-2010) (sch 34826)
18503120

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forlani, A; Monopoli, A; Ongini, E1
Chiu, PJ; Sybertz, EJ; Vemulapalli, S; Watkins, RW1

Other Studies

2 other study(ies) available for sch 42495 and sch 34826

ArticleYear
Chronic inhibition of neutral endopeptidase reduces left ventricular hypertrophy without changing blood pressure in spontaneously hypertensive rats.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1991, Volume: 9, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Dioxolanes; Dipeptides; Enalapril; Hypertension; Methionine; Myocardium; Neprilysin; Rats; Rats, Inbred SHR

1991
Neutral metalloendopeptidase inhibition: a novel means of circulatory modulation.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1990, Volume: 8, Issue:7

    Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Desoxycorticosterone; Dioxolanes; Dipeptides; Hypertension; Male; Methionine; Neprilysin; Rats; Rats, Inbred Strains; Sodium, Dietary

1990